1 January 2016 in Neural Plasticity
In the present study, we investigated whether restoring descending noradrenergic inhibitory tone can attenuate pain in a PD rat model, which was established by stereotaxic infusion of 6-hydroxydopamine (6-OHDA) into the bilateral striatum (CPu). PD rats developed thermal and mechanical hypersensitivity at the 4th week after surgery. HPLC analysis showed that NE content, but not dopamine or 5-HT, significantly decreased in lumbar spinal cord in PD rats. Additional noradrenergic depletion by injection of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) aggravated pain hypersensitivity in PD rats. At the 5th week after injection of 6-OHDA, systemic treatment with pharmacological norepinephrine (NE) precursor droxidopa (L-DOPS) or2 adrenoceptor agonist clonidine significantly attenuated thermal and mechanical pain hypersensitivity in PD rats. Furthermore, application of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) reuptake inhibitors duloxetine, but not 5-HT selective reuptake inhibitors sertraline, significantly inhibited thermal and mechanical pain hypersensitivity in PD rats. Systemic administration of Madopar (L-DOPA) or the D2/D3 agonist pramipexole slightly inhibited the thermal, but not mechanical, hypersensitivity in PD rats. Thus, our study revealed that impairment of descending noradrenergic system may play a key role in PD-associated pain and restoring spinal noradrenergic inhibitory tone may serve as a novel strategy to manage PD-associated pain.
4 November 2025 in Journal of Cell Biology
Circadian clocks orchestrate the daily rhythms of physiological functions. The underlying mechanisms of circadian clocks are highly conserved across species, driven by endogenous transcriptional–translational feedback loops. CLOCK, a central transcription factor in circadian regulation, requires coregulatory factors and histone modification dynamics to regulate downstream clock-controlled gene expression. In this study, we identify the Drosophila polymerase-associated factor 1 complex (Paf1C) as a previously unrecognized regulator of the circadian transcriptional machinery. We found that knocking down different subunits of Paf1C in pacemaker neurons lengthens the circadian locomotion period. Specifically, downregulation of rtf1, a core subunit of Paf1C, significantly dampens the amplitude of circadian rhythms and extends the locomotor period. This effect is primarily attributed to a reduction in the pacemaker protein PERIOD (PER), mediated through decreased per transcription. Indeed, the overexpression of per in pacemaker neurons rescues the circadian defects caused by rtf1 downregulation. Mechanistically, we identified that rtf1 enhances CLK-mediated per transcription activation. RTF1 physically interacts with CLK, thus promoting its occupancy on the promoters of per and other clock genes. Furthermore, the H3K4me3 methyltransferase SET1 forms complex with CLK and RTF1, facilitates their interaction, and thereby increases H3K4me3 levels at the per/tim promoter to promote their expression. Notably, we discovered that human RTF1 physically interacts with BMAL1/CLOCK and affects the circadian rhythms in U2OS cells, indicating a potentially conserved mechanism in mammals. Together, our results demonstrate that RTF1 regulates circadian rhythms by modulating CLK occupancy and H3K4me3 levels at pacemaker gene promoters.